kabutan

TAUNS Laboratories,Inc.(197A) Summary

197A
TSE Standard
TAUNS Laboratories,Inc.
511
JPY
-1
(-0.20%)
Dec 5, 12:48 pm JST
3.29
USD
Dec 4, 10:48 pm EST
Result
PTS
outside of trading hours
511.9
Dec 5, 12:47 pm JST
Summary Chart Historical News Financial Result
PER
6.1
PBR
3.40
Yield
5.48%
Margin Trading Ratio
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
514 JPY 3.31 USD
Previous Close Dec 4
512 JPY 3.29 USD
High Dec 5, 9:00 am
514 JPY 3.31 USD
Low Dec 5, 9:04 am
510 JPY 3.28 USD
Volume
130,500
Trading Value
0.07B JPY 0.43M USD
VWAP
511.7 JPY 3.3 USD
Minimum Trading Value
51,100 JPY 329 USD
Market Cap
0.05T JPY 0.34B USD
Number of Trades
105
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly High
1-Year Average
804
1-Year High Jan 10, 2025
9,012
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 19,000 2,675,000 140.79
Nov 21, 2025 34,900 2,668,900 76.47
Nov 14, 2025 55,400 2,641,500 47.68
Nov 7, 2025 39,700 2,536,700 63.90
Oct 31, 2025 33,000 2,552,400 77.35
Company Profile
TAUNS Laboratories, Inc. specializes in the development and manufacture of in vitro diagnostic medical devices and research reagents.
Sector
Pharmaceuticals
TAUNS Laboratories, Inc. focuses on the development and manufacture of in vitro diagnostic medical devices and research reagents as its core business, primarily offering antigen test kits for infectious disease clinical testing. By utilizing the immunochromatographic method, the company enables rapid diagnosis without the need for specialized equipment. Key features of their products include the common use of specimen extraction solution and high visibility black lines achieved through their proprietary "platinum-gold colloid" nanotechnology. The company provides its products to domestic and international medical institutions, international organizations, research institutes, and biotech ventures. Their main product line includes test kits for influenza, novel coronavirus, adenovirus, and RSV, among others.